| NCT ID | NCT04754217 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Abbott Medical Devices |
| Condition | Aortic Valve Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 260 participants |
| Start Date | 2021-07-13 |
| Primary Completion | 2029-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 260 participants in total. It began in 2021-07-13 with a primary completion date of 2029-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
Eligibility Criteria
Inclusion Criteria: * cardiac surgery including the implant of a VAVGJ or CAVGJ for native or prosthetic valve replacement Exclusion Criteria: * anticoagulation therapy intolerant * active endocarditis * anatomical or medical, surgical, psychological or social contraindications
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04754217 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aortic Valve Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04754217 currently recruiting?
Yes, NCT04754217 is actively recruiting participants. Contact the research team at paolo.amato@abbott.com for enrollment information.
Where is the NCT04754217 trial being conducted?
This trial is being conducted at Birmingham, United States, Ann Arbor, United States, Asheville, United States, Philadelphia, United States and 11 additional locations.
Who is sponsoring the NCT04754217 clinical trial?
NCT04754217 is sponsored by Abbott Medical Devices. The trial plans to enroll 260 participants.